08/11/2024 |
AA amyloidosis: a severe disease but also a model for studying amyloid-related questions |
Gunilla Westermark |
11/11/2024 |
Novel molecular mechanisms of Spinocerebellar Ataxia Type 7 and ALS Neurodegeneration |
Albert La Spada |
27/11/2024 |
An overview on Europe's key role for research and innovation |
Maria Leptin |
27/11/2024 |
The European research trajectory on Parkinson's disease from early stem cell research to the first-in-human trasplantation in patients |
Andres Bjorklund, Malin Parmar, Roger Barker |
27/11/2024 |
The US effort and results in the field of stem cells for Parkinson's disease: synergies and joint efforts with Europe |
Viviane Tabar, Lorenz Studer |
27/11/2024 |
The social, economic and industrial empact of European research policies |
Arjon van Hengel, Sofia Hakansson Buch |
27/11/2024 |
40 years of research on cell therapy for Parkinson's disease |
Anders Bjorklund |
27/11/2024 |
First and second-generation strategies in developing a cell-based therapy for Parkinson's disease |
Lorenz Studer |
31/01/2025 |
Sialoconjugates as new players in Huntington's disease: insight into molecular mechanisms and potential therapies |
Vittorio Maglione |